Inactive Instrument
Prevail Therapeutics Inc. Stock
Stocks
PRVL
US74140Y1010
Biotechnology & Medical Research
| 1 day | -0.09% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emily Minkow
PRN | Corporate Officer/Principal | 43 | 2018-10-31 |
Yong Dai
PRN | Corporate Officer/Principal | 55 | 2019-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/22/21 | Issuer sale | Chief Executive Officer | 388,939 | 1.1357% | ||
| 1/22/21 | Issuer sale | Director | 37,000 | 0.1080% | ||
| 1/22/21 | OrbiMed Advisors Private Equity
| Tender | Company | 13,822,463 | 40.3599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | +0.39% | - | - | 788M | |
| -0.31% | +5.79% | +47.13% | +99.53% | 70.88B | |
| -1.03% | +2.06% | +39.38% | +78.71% | 62.49B | |
| +5.36% | +7.96% | +32.36% | +30.18% | 26.34B | |
| -3.21% | -7.27% | -17.10% | +370.22% | 26.21B | |
| -2.64% | -0.69% | -0.17% | -11.56% | 24.13B | |
| -0.31% | +8.03% | +25.03% | -13.74% | 20.72B | |
| +2.12% | -5.86% | +161.58% | +333.73% | 15.69B | |
| -0.22% | +3.99% | +45.54% | +171.32% | 14.46B | |
| +0.73% | +1.71% | -5.51% | +859.68% | 14.24B | |
| Average | +0.28% | +1.74% | +36.47% | +213.12% | 30.57B | |
| Weighted average by Cap. | +0.18% | +1.49% | +35.74% | +152.14% |
Employees
-
